Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic.
Lower urinary tract symptoms of neurological origin in urological practice.
Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatment.
Identification of Risk Factors for Falls in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Triptolide with Potential Medicinal Value for Diseases of the Central Nervous System.
Risk of relapse phenotype recurrence in multiple sclerosis.
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis.
Paroxysmal chorea as a relapse of myelopathy in a patient with neuromyelitis optica.
Notch Signaling Regulates T Cell Accumulation and Function in the Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Hypoxia Inducible Factor-1α in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease(,.)
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis.
Exome sequencing to find rare variants causing neurologic diseases.
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?
A new therapeutic target for the treatment of multiple sclerosis.
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria.
Multiple Sclerosis: Does Nogo Play a Role?
Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients.
Clinical trials to clinical use: using vision as a model for multiple sclerosis and beyond.
Clostridia as agents of zoonotic disease.
A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis.
The Choroid Plexus in Healthy and Diseased Brain.
Pages
« first
‹ previous
…
299
300
301
302
303
304
305
306
307
…
next ›
last »